KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Q3 2025 value amounting to 0.59%.

  • Ginkgo Bioworks Holdings' Return on Invested Capital rose 1800.0% to 0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.62% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Return on Invested Capital stood at 0.59%, which was up 1800.0% from 0.5% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Return on Invested Capital high stood at 0.2% for Q3 2021, and its period low was 2.43% during Q3 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Return on Invested Capital value was 0.79% (recorded in 2024), while the average stood at 0.97%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -22300bps in 2022, then skyrocketed by 17700bps in 2023.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Return on Invested Capital stood at 1.15% in 2021, then dropped by -20bps to 1.38% in 2022, then surged by 47bps to 0.74% in 2023, then decreased by 0bps to 0.74% in 2024, then grew by 20bps to 0.59% in 2025.
  • Its Return on Invested Capital was 0.59% in Q3 2025, compared to 0.5% in Q2 2025 and 0.69% in Q1 2025.